All Posts Tagged Tag: ‘Johnson & Johnson’

J&J Company to Pay $1.25 Million Over Expiration Dates

The U.S. Food and Drug Administration (FDA) today announced that it has settled a civil penalty case against Johnson & Johnson company Advanced Sterilization Products (ASP). ASP has agreed to pay $1.25 million over misbranded products that it distributed. Two ASP executives have also settled with the FDA over the matter. ASP President Bernard Zovighian has agreed to pay $30,000 …

Read More

Johnson & Johnson to Pay $2.5 Billion Over Hip Replacements

In January of this year a class-action lawsuit against Johnson & Johnson began. The lawsuit revolved around the company’s 2010 recall of hip replacements and whether Johnson & Johnson subsidiary DePuy Orthopaedics knew that the devices could release small bits of metal particles into the bodies of patients. Johnson & Johnson this week announced that it has agreed to a …

Read More

Johnson & Johnson to Pay $2.2 Billion Over Risperdal Claims

The U.S. Department of Justice and the U.S. Food and Drug Administration (FDA) today announced that Janssen Pharmaceuticals has plead guilty over the misbranding of the drug Risperdal. Janssen and its company, Johnson & Johnson, will pay a total of $2.2 billion to settle the matter. Around $485 million of the amount will be paid in the form of a …

Read More

Infant Motrin Recall For 200,000 Bottles

Nearly 200,000 bottles of Concentrated Motrin Infants’ Drops have been recalled due to plastic particles. According to the Motrin website, the medicine is used to reduce fever as well as relieve minor aches and pains related to the multiple ailments such as the common cold, flu, toothaches, headaches, and a sore throat. Johnson & Johnson released an announcement on behalf …

Read More

Infant Motrin Recall Due To Potential Plastic Contamination Still In Effect

Infant Motrin is being recalled this week and Johnson & Johnson has voluntarily pulled 200,000 bottles off the shelves due to the risk of contamination by plastic particles. The company first issued a notice back in September about the recall and have said the recall is still in effect. The medicine–concentrated drops in original berry flavor–carries lot numbers of DCB3T01, …

Read More

Hip Implants Trial Against Johnson & Johnson Begins

The first of many lawsuits filed against Johnson & Johnson over the company’s 2010 recall of hip replacements has begun in Los Angeles. According to a Reuters report, 66-year-old Loren Kransky is alleging that Johnson & Johnson subsidiary DePuy knew their implants could release metal into patients’ bodies. DePuy contends that Kransky was a life-long smoker with diabetes and kidney …

Read More

Diabetes Drug Approved by U.S. FDA Committee

A U.S. Food and Drug Administration (FDA) committee this week approved the drug canagliflozin for the treatment of adults with type 2 diabetes. The Endrocrinologic and Metabolic Drugs Advisory Committee of the FDA voted 10 to 5 to approve the drug. Canagliflozin, which Johnson & Johnson has given the proposed trade name of Invokana, will, if further approved by the …

Read More